NASDAQ (usa) | 6715.56 | -12.11 | -0.18% | |
FTSE 100 (london) | 7487.96 | -5.12 | -0.07% | |
DAX (german) | 13465.51 | 235.94 | 1.78% | |
NIKKEI 225 (japan) | 22420.08 | 408.47 | 1.86% | |
Hang - Seng (hong kong) | 28594.06 | 348.52 | 1.23% |
NIFTY - 50 (india) | ||||
Straits Times (singapore) | 3391.61 | 17.53 | 0.52% | |
KOSPI (korea) | 2556.47 | 33.04 | 1.31% | |
All Ordinaries (australia) | 6005.30 | 28.90 | 0.48% | |
BOVESPA (brazil) | 74092.76 | -215.73 | -0.29% |
Shenzhen Weiguang Biological Products Co. Ltd (SHE: 002880)
002880 Technical Analysis
5
As on 9th Jun 2023 002880 STOCK Price closed @ 38.15 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 27.65 & Strong Buy for SHORT-TERM with Stoploss of 31.80 we also expect STOCK to react on Following IMPORTANT LEVELS. |
002880STOCK Price
Open | 39.50 | Change | Price | % |
High | 41.35 | 1 Day | -1.21 | -3.07 |
Low | 37.89 | 1 Week | 5.20 | 15.78 |
Close | 38.15 | 1 Month | 6.72 | 21.38 |
Volume | 4616853 | 1 Year | 6.98 | 22.39 |
52 Week High 40.32 | 52 Week Low 22.09 |
SHE China Most Active Stocks
000100 | 3.90 | 1.04% |
300315 | 6.32 | 19.92% |
002602 | 7.57 | 10.03% |
300459 | 6.89 | 4.71% |
000725 | 4.00 | 1.78% |
300002 | 14.07 | 9.92% |
300058 | 10.87 | 1.68% |
002354 | 7.41 | 4.66% |
300059 | 14.23 | -1.59% |
002292 | 11.19 | -4.44% |
SHE China Top Gainers Stocks
SHE China Top Losers Stocks
002880 Daily Charts |
002880 Intraday Charts |
Whats New @ Bazaartrend |
002880 Free Analysis |
|
002880 Important Levels Intraday
RESISTANCE | 44.82 |
RESISTANCE | 42.68 |
RESISTANCE | 41.36 |
RESISTANCE | 40.04 |
SUPPORT | 36.26 |
SUPPORT | 34.94 |
SUPPORT | 33.62 |
SUPPORT | 31.48 |
002880 Forecast May 2024
4th UP Forecast | 51.93 |
3rd UP Forecast | 47.51 |
2nd UP Forecast | 44.78 |
1st UP Forecast | 42.05 |
1st DOWN Forecast | 34.25 |
2nd DOWN Forecast | 31.52 |
3rd DOWN Forecast | 28.79 |
4th DOWN Forecast | 24.37 |
002880 Weekly Forecast
4th UP Forecast | 48.11 |
3rd UP Forecast | 44.92 |
2nd UP Forecast | 42.94 |
1st UP Forecast | 40.97 |
1st DOWN Forecast | 35.33 |
2nd DOWN Forecast | 33.36 |
3rd DOWN Forecast | 31.38 |
4th DOWN Forecast | 28.19 |
002880 Forecast2024
4th UP Forecast | 76.56 |
3rd UP Forecast | 64.24 |
2nd UP Forecast | 56.63 |
1st UP Forecast | 49.01 |
1st DOWN Forecast | 27.29 |
2nd DOWN Forecast | 19.67 |
3rd DOWN Forecast | 12.06 |
4th DOWN Forecast | -0.26 |
Shenzhen Weiguang Biological Products Co. Ltd ( SHE China Symbol : 002880 )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
002880 Other Details
Segment | EQ | |
Market Capital | 6504624128.00 | |
Sector | Healthcare | |
Industry | Drug Manufacturers-Specialty & Generic | |
Offical website | > echo $website ; ?> |
002880 Address
002880 Latest News
002880 Business Profile
Shenzhen Weiguang Biological Products Co., Ltd. primarily engages in the research, development, production, and sale of blood products in China. The company offers human albumin, intravenous immunoglobulin (pH4), freeze-dried intravenous human immunoglobulin (pH4), human immunoglobulin, hepatitis B human immunoglobulin, rabies patient immunoglobulin, tetanus human immunoglobulin, histamine human immunoglobulin, and human fibrinogen, as well as a total of 9 varieties and 21 specifications. Shenzhen Weiguang Biological Products Co., Ltd. was founded in 1985 and is based in Shenzhen, China. Address: No. 3402, Guangqiao Avenue, Shenzhen, China, 518107
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service